Bechara J. Saab1, Joanes Grandjean2, Alberto Corcoba3, Martin C. Kahn4, Louise A. Upton4, Erich Seifritz1, Fritjof Helmchen5, Isabelle Mansuy1, Edward O. Mann4, and Markus Rudin2
1University of Zurich, Zurich, Switzerland, 2University and ETH Zurich, Zurich, Switzerland, 3EPFL, Lausanne, Switzerland, 4University of Oxford, Oxford, United Kingdom, 5University and ETH Zurich, Zuerich, Switzerland
Synopsis
Mouse
functional MRI was used to investigate the effect of selective stimulation of
serotonergic neurons of the dorsal raphe via channelorodopsin-mediated optical
control. Electrophysiological recordings in the nucleus and in projection areas
confirmed neuronal activity changes upon illumination with blue light. Acute pharmacological
modulation with fluoxetine, a serotonin reuptake inhibitor, lead to increased CBV
response upon 5HT release, while animal restraint prior to measurements lead to
a reduction of the elicited response. This study demonstrates the feasibility
to assess a neurotransmitter function non-invasively at a whole brain level and
investigate alterations in mood-controlling systems.Introduction
Acute averse
life events may prompt dynamic reorganization of neuronal networks, which eventually
might lead to psychiatric disorders such as depression. The serotonergic (5HT)
system in the dorsal raphe nucleus, a major system involved in mood control, is
known to be susceptible to such events. The neurons in this nucleus project to
distributed regions throughout the brain, in particular to regions in the
limbic system, the hippocampus, the amygdala, and the prefrontal cortex. Mouse fMRI offers a unique opportunity to
investigate non-invasively modifications of the neurotransmitter system at the
whole brain level induced by pharmacological modulation, or stressful life
events. In this study we used optogenetic methods to dynamically control 5HT
neurons in the dorsal raphe nucleus assessing dynamic changes in cerebral blood
volume (CBV) as fMRI readout. Electrophysiological recordings confirmed the
neuronal nature of the response.
Method
ePet-cre transgenic mice expressing cre
recombinase in 5HT neurons and wild-type controls were stereotactically
injected in the dorsal raphe nucleus with adeno-associated viruses containing a
sequence encoding for the channelorodopsin2 fused with enhanced yellow
fluorescent protein (ChR2-eYFP). Two weeks later, a light-fiber implant was
surgically inserted at the site of the dorsal raphe nucleus. Histological staining were performed to
confirm the expression of ChR2-eYFP and colocalization with 5HT. Local field
potential and multi-unit recordings were performed on brain slices and in vivo.
CBV-fMRI measurements were performed on a 7T Bruker Pharmascan system with a
transmit/receive surface coil using multi-shot gradient-echo EPI, TE 5.6ms, TR
1000ms, FA 90°, 2 segment, 0.315x0.273mm² in plane resolution. Freely breathing animals were anesthetized
with isoflurane 0.5% and medetomidine 0.1mg/kg bolus and 0.2 mg/kg/h infusion
s.c. Iron nanoparticles were injected i.v. prior to fMRI experiments. 6 blocks
of 20s blue-light stimulation consisting of 5ms pulse at 20Hz and laser power
set at 40mW were spaced 160s apart for the stimulation of the 5HT system
(control group, n=17). In a group of mice (n=9) Fluoxetine (4.5 mg/kg i.v.) was administered before the fMRI scan to modulated serotonergic
signaling. Finally, to mimic a stress response a group of animals (n=7) were
held in a restrainer for 60 min before undergoing fMRI. GLM
analysis was performed on motion corrected and high-pass filtered time series
by modeling each stimulation individually. Second level analysis was performed
to compare fluoxetine vs. control and restrain vs. control. Statistical maps
were corrected with threshold-free cluster enhancement.
Result
Histological analysis confirms the expression of
ChR2 confined in the dorsal raphe nucleus (Fig 1A), and in projection areas
such as in the prefrontal cortex (Fig 1B&C). Electrophysiological
recordings indicate increased spiking rate in dorsal raphe nucleus upon blue
light stimulation (Fig 2A), but decreased spiking rate (Fig 2B) and local field
potential power (Fig 2C) in sensory cortex.
Blue light stimulation elicited an increase in CBV in the dorsal raphe,
and a corresponding decrease in the projection area, including isocortex, caudate
putamen, and hippocampi (Fig 3 A&B). No CBV changes have been observed in
wild-type controls, which could not integrate the ChR2-eYFP coding sequence
(Fig 3A). Statistical comparisons of fluoxetine vs. control conditions indicate
an increase in response amplitude elicited following fluoxetine injection
across the projection areas (Fig 4A), while restraint prior to fMRI session
lead to the opposite effect in these regions (Fig 4B).
Discussion
The tight
control of local neuronal networks represents a crucial element in
mood-regulation in the healthy and disordered brain. The ability to follow the changes in the circuits
involved in mood disorders non-invasively and over long period of times is
attractive to understand the pathological alterations induced by stressful
events, and to understand the effects of mood-altering pharmacological
intervention on specific neurotransmitter systems. Optogenetic modification of
5HT neurons allows for a dynamical control of selected neurons, which in turn
elicit a robust neuronal and hemodynamic response. The response observed
correspond to the expected serotonin projection areas. We could not find
indication of unspecific effects as reported in earlier reports as indicated by
the lack of response in control animals. The CBV-fMRI response was susceptible
to both pharmacological and behavioural modulation. Indeed, the amplitude of
the CBV response in the projection areas was increased following fluoxetine
administration, consistent with elevated 5HT transmission induced by the 5HT
reuptake inhibitors. Restraint leads to an opposite effect, a decrease in CBV
response, which indicates a reduction in 5HT transmission following stressful
events. Opto-fMRI allows for a sensitive read-out to follow specific circuits
involved brain disorders, and may thus allow a mechanistic understanding the
effect of pharmacological action on these circuits.
Acknowledgements
No acknowledgement found.References
No reference found.